Drug · DIN 02499681
ENSPRYNG
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 26, 2020; first marketed August 26, 2020.
- Drug Identification Number (DIN)
- 02499681
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Satralizumab L04AC19
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SATRALIZUMAB | 120 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 1, 2020: NOC 23701New Drug Submission (NDS)